The WHO has trained over 200 African regulatory staff and is continuing to build capacity to prevent, detect and respond to substandard and falsified medical products. Representation of the WHO as well as the Uppsala Monitoring Centre and the Collaborating Centre for Advocacy and Training in Pharmacovigilance in Accra, Ghana, will steer our activities and findings. The materials developed during PAVIA will be available through the WHO CCs, including Lareb, both during and after the project.